GL1X · GenesisL1 explorer

MolNFT v1 · #24125 · protein

Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors

1ULA: “Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase…”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.61). MolNFT v1 #24125 on GenesisL1: 3D structure, binding…

PDB
1ULA
Type
protein
Length
289 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Purine nucleoside phosphorylase
EC
2.4.2.1
UniProt
P00491
Ligands
SO4
Pockets
2 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APurine nucleoside phosphorylase (EC 2.4.2.1)protein28930% helix, 20% strandP00491

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13330.610.7846SO4
2640.450.8318empty

Compared structures

  • 1ULA · Application of crystallographic and modeling methods in the design of purine nucleoside… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00491 · AlphaFold monomer V2.0 prediction for purine nucleoside phosphorylase (P00491) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.